Glutamine supplementation for cystic fibrosis: a parallel group randomized controlled trial - Glutamine and CF
Phase 1
- Conditions
- Cystic fibrosisMedDRA version: 9.1 Level: LLT Classification code 10011762 Term: Cystic fibrosis
- Registration Number
- EUCTR2007-006204-37-GB
- Lead Sponsor
- niversity of Nottingham
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
age 14-45 years old
consent to participate in study
FEV1 >25%, <80%
previous colonisation with pseudomonas
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
current pregnancy or breastfeeding
recent pulmonary exacerbation
lung transplant
recently diagnosed diabetes or uncontrolled diabetes
severe liver failure
involvement in another clinica trial
initiation of new pulmonary therapies in past year
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method